SC Filed 2019-07-12 Event — SEC 0001193125-19-193234 →

SVF Investments (UK) Ltd → Axovant Gene Therapies Ltd.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

16 13D/G filings on this issuer

15 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Axovant Gene Therapies Ltd.

Filed	Form	Filer	Stake	Shares
2019-12-31	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-17	SC	Lo Andrew	—	—	view →
2019-07-16	SC	Machado Patrick	—	—	view →
2019-07-16	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-12	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2019-07-12	SC	Dexxon Holdings Ltd.	—	—	view →
2019-07-12	SC	QVT Financial LP	—	—	view →
2019-03-19	SC	Machado Patrick	—	—	view →
2019-03-19	SC	Roivant Sciences Ltd.	—	—	view →
2019-03-19	SC	QVT Financial LP	—	—	view →
2019-03-19	SC	Dexxon Holdings Ltd.	—	—	view →
2019-03-19	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2019-03-19	SC	Lo Andrew	—	—	view →
2019-03-19	SC	SVF Investments (UK) Ltd	—	—	view →
2019-01-03	SC	VIKING GLOBAL INVESTORS LP	—	—	view →

Other Filings by SVF Investments (UK) Ltd

Filed	Form	Issuer	Stake	Shares
2019-07-12	SC	Myovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-06-05	SC	Myovant Sciences Ltd.	—	—	view →
2019-03-19	SC	Axovant Sciences Ltd.	—	—	view →
2018-04-04	SC	Myovant Sciences Ltd.	—	—	view →
2018-01-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →